| Followers | 21 |
| Posts | 1402 |
| Boards Moderated | 0 |
| Alias Born | 03/03/2021 |
Wednesday, August 11, 2021 2:39:57 PM
ABTA Thx branster.. my thoughts..
So, it is on lunchbreak, so, more a conversation piece than anything. Which makes sense due to no "big phamra" sponsoring.
I listened to last years Youtube and LP was kinda explaining DCVax as if it was for non-oncologists, or perhaps heavy on Med Students.
I gotta a super strong feeling, from the title, it will be about what Dr Liau has been talking about lately, using historical data for trials. And yes, on GBM, we know the stats(you die, fast)...so, all people in a trial should get the Vax/drug.
Hopefully, LP will mention event at a 10Q call to dispell TLD at this event. (I would hate to play chess with her).
Never the less, I will be ready to take advantage of Bear Attacks with my new Bear Spray.
So, it is on lunchbreak, so, more a conversation piece than anything. Which makes sense due to no "big phamra" sponsoring.
I listened to last years Youtube and LP was kinda explaining DCVax as if it was for non-oncologists, or perhaps heavy on Med Students.
2:46.22
I gotta a super strong feeling, from the title, it will be about what Dr Liau has been talking about lately, using historical data for trials. And yes, on GBM, we know the stats(you die, fast)...so, all people in a trial should get the Vax/drug.
Hopefully, LP will mention event at a 10Q call to dispell TLD at this event. (I would hate to play chess with her).
Never the less, I will be ready to take advantage of Bear Attacks with my new Bear Spray.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
